Prasad G V, Abidi S M, McCauley J, Johnston J R
Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Am J Kidney Dis. 1999 May;33(5):963-5. doi: 10.1016/s0272-6386(99)70433-6.
Vitamin K deficiency is a common occurrence in the surgical and intensive care unit population, but its incidence in kidney and combined kidney-pancreas allograft recipients has not been described. We report four patients who received cadaveric kidney or combined kidney-pancreas allografts and subsequently developed significant bleeding associated with deficiency of vitamin K. Their coagulopathy promptly resolved with the parenteral administration of vitamin K. Treatment with vitamin K should be considered in kidney or combined kidney-pancreas allograft recipients with a prolonged prothrombin or partial thromboplastin time during the first postoperative week to avoid hemorrhagic complications.
维生素K缺乏在外科和重症监护病房患者中很常见,但在肾移植受者以及肾-胰联合移植受者中的发生率尚未见报道。我们报告了4例接受尸体肾移植或肾-胰联合移植的患者,这些患者随后出现了与维生素K缺乏相关的严重出血。通过胃肠外给予维生素K,他们的凝血病迅速得到缓解。对于术后第一周内凝血酶原时间或部分凝血活酶时间延长的肾移植或肾-胰联合移植受者,应考虑使用维生素K进行治疗,以避免出血并发症。